• Safe & Effective
  • Kind & Caring
  • Exceeding Expectation
Trust in Top Ten for Clinical Trial Participants

Trust in Top Ten for Clinical Trial Participants

Date of release: 20 May 2020

The Royal Wolverhampton NHS Trust has featured in the top ten hospital trusts in the UK for the highest number of participants involved in COVID-19 studies researching the virus, coinciding with International Clinical Trials Day #CTD2020.

The organisation has recruited a total of 793 patients to participate across a series of nine research studies, from a total of 9,742 patients involved in 20 such studies across the West Midlands. This region is currently recruiting more participants to COVID-19 studies than any other in the UK, with three of its Trusts featuring in the top ten based on figures for Tuesday May 19th - University Hospitals Birmingham are in first and University Hospitals North Midlands in sixth position. Nationally, 70,664 patients are taking part in 26 different studies.

The COVID-19 studies the Trust have recruited most patients to are related to breathing difficulties, pneumonia, a review of the triage of people using the emergency care system, pregnancy and why some patients are more susceptible than others to the disease.

The Trust has welcomed the announcement as a success of the determination of the city to do all it can in the fight against coronavirus in such challenging times. Professor Matt Brookes, researcher at the Trust, said: “The challenges to our clinical teams in recent months have been significant. We all knew that there were limited treatment options for COVID-19 and as such our clinicians and researchers realised the importance of research studies in an attempt to battle this virus. To have delivered such a breadth and depth of research at this time is an amazing achievement. This is down to successful collaborative working between our Trust’s management teams, clinicians, researchers and their positive engagement with our colleagues in the clinical research network.

“This proactive team-working has enabled the Trust’s team to provide access for a huge number of patients to these research studies. All of these outcomes will be fed back nationally to allow us to be better informed about successful treatment options against COVID-19 for the future.”

Network Clinical Director of the Clinical Research Network West Midlands, Professor Jeremy Kirk, part of the National Institute for Health Research, said: “In these extraordinary times it is both amazing and very heartening to see the hard-pressed NHS staff nationally, and especially in the West Midlands, coming together to recruit as many patients with COVID-19 as possible into these ground-breaking trials. Our collaborations are offering research opportunities to thousands of patients and we thank everyone who is taking part.”

***ENDS***

Notes to Editor

Press release issued by the Communications team. For more information contact the team on 01902 442600

A Teaching Trust of the University of Birmingham